The Ark
A blog about our science, the rare disease community and PerlQuests
Hit to lead, lead to partnership
This is the fourth post in an open science blog series about PERL101 (P101), a small...
Funding announcement
This week we announced a $7.4M equity financing. Endpoints News and STAT News covered...
From Dead to Alive with a Small Molecule
Perlara's high throughput screen progress in Mucolipidosis IV (MLIV) flies… In this...
Developing a fly model of Niemann-Pick Type A
By Taryn Sumabat This summer at Perlara, we ramped up our efforts to develop a...
Midsummer updates
Perlara midsummer 2017 updates—We took a temporary hiatus from blogging starting in...
World Rare Disease Day 2017
This post is dedicated to World Rare Disease Day (WRDD) 2017. It was at the WRRD four...
Optimizing my first High Throughput Screen
I, along with Nina, performed our first high-throughput screen – well really...
NPC1 KO mouse brain study
Well it has been a little while since I wrote a post, and a lot has happened since...
2016 in review
"Last Month in Tweets" was on again, off again in 2016. Apologies, we'll be more...
From Pitch to Partnership – 3 years of Perlara spending
As 2016 draws to a close, we look back on two and half years of Perlara spending....
Perlara’s first preprint
Two weeks ago we posted Perlara's first preprint to bioRxiv, along with all the raw...
Echo 550 acoustic liquid handling technology
High throughput screening (HTS) is essential in the process of finding a potential...
